Data / Form D filings / CAMBRIDGE EPIGENETIX Ltd
CAMBRIDGE EPIGENETIX Ltd: Form D filing
CAMBRIDGE EPIGENETIX Ltd, a biotechnology company in Cambridge, United Kingdom, filed a Form D with the SEC in 2018. The latest, on May 9, 2018, reports $12.3 million sold of a $12.3 million offering to 15 investors.
Find out what CAMBRIDGE EPIGENETIX Ltd does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 30 Broad Street, Great Cambourne, Cambridge, United Kingdom, CB23
- Phone
- +44 1223 800700
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- United Kingdom
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1739567
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 9, 2018 | New notice | $12,294,237 | $12,294,237 | $0 | 15 | Apr 18, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Martin Murphy | Director | |
| Jason Mellad | Executive Officer, Director | |
| Bobby Yerramilli-Rao | Director | |
| Alice Newcombe-Ellis | Director | |
| Somasundaram Subramaniam | Director | |
| Timothy Rink | Director | |
| Thomas Hulme | Director | |
| Shankar Balasubramanian | Director |
Every Form D from the week of May 7, 2018 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CAMBRIDGE EPIGENETIX Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.